Wikipedia -WSS

Wikipedia

author：knowledge 2025-09-29 16:35:51 - browse：979

Mayo Clinic, in Rochester, Minnesota on — Photo by KEREM YUCEL/AFP via Getty Images

SAN FRANCISCO — Mayo Clinic has signed Silicon Valley tech startup Cerebras as its first generative AI partner, the health system announced Monday.

The health system — known for its cutting-edge research and willingness to partner with tech companies — will give Cerebras millions of dollars to help build technology tools based on Mayo’s trove of de-identified patient data, leaders announced at the J.P. Morgan Healthcare Conference. Mayo and Cerebras did not disclose the dollar amount, but Cerebras said it was a multimillion, multi-year contract.

With roughly 380 employees, Cerebras builds and sells supercomputers specifically designed for AI applications across several industries — pitting the upstart in direct competition with the market leader Nvidia Corp. Life sciences giants including GSK have used its technology for drug discovery, and it has partnered with a health network in United Arab Emirates, but this is Cerebras’ first AI contract with a U.S. health system. The deal gives Mayo access to Cerebras’ supercomputers as well as a Cerebras team to help develop health-tuned models; Mayo will then own whatever they build.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： STAT Summit: Michael J. Fox on progress in Parkinson's research

hotspot

WSS

Cholera vaccine supply gets boost as demand surges globally

NIH confirmation hearing shows politicization of research

Melinda French Gates resigns from Gates Foundation

2023 STAT Wunderkinds: get to know the winners

Diversity in clinical trials starts with building trust, experts say

Senate committee scrutinizes Medicare Advantage brokers

leisure time

Wikipedia

hotspot

Continuity nursing helped my family in our darkest PICU moments

Q&A: Jennifer Adair on making gene therapy available globally

BioMarin wins approval for gene therapy to treat hemophilia A

Orangutan used medicinal plant to treat wound, first time ever seen

Moonlake's readout produced a cash windfall. Risks remain

FDA gives detailed accounting of AI

DIEP, the 'gold standard' of breast reconstruction, is under threat

First Opinion Podcast: Long Covid needs a new approach

BioMarin wins approval for gene therapy to treat hemophilia A

Solve the antibiotic resistance crisis with preventive drugs

leisure time

Health care needs a new profession: neuroimaging counseling

2023 STAT Wunderkinds: get to know the winners

Cancer researcher Catriona Jamieson is sending tumors into space

First Opinion Podcast: Long Covid needs a new approach

FDA struggles to regulate food additives, sometimes for decades

Cue Health's Covid

entertainment

hotspot

entertainment

knowledge